ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours

Table 1

Patient and tumour demographics.

Characteristic	Total group	Male	Female	% of all SBNETs
Site of primary tumor
Duodenum	3	3	0	2.2
Jejunum	4	2	2	3
Ileum	131	63	68	94.8
Total	138	68	70
TNM stage at diagnosis
Stage 1	0	0	0	0
Stage 2	4	3	1	3
Stage 3	23	10	13	16.7
Stage 4	91	42	49	66
Stage unknown	20	13	7	14.5
Median age	65	67	64
Age range	29–87	31–87	29–82
Tumour grade
G1	51	22	29
G2	25	15	10
G3	0	0	0
Not available	62	31	31
Functional tumour	76			55
Nonfunctional tumour	62			45

SBNETs: small bowel NETs.